Shoulder arthritis is a condition characterized by the gradual breakdown of the cartilage within the shoulder joint, leading to pain, stiffness, and reduced range of motion. It most commonly affects the glenohumeral joint (where the upper arm bone, or humerus, meets the shoulder blade, or scapula) and the acromioclavicular (AC) joint (where the collarbone meets the shoulder blade).
Procedures using ORTHOReNEW Regenexx injectates for degenerative arthritis of the shoulder joint is a proven alternative for people looking to avoid surgery, lengthy recovery, and overuse of prescription pain medication. Best of all, procedures spare normal body biomechanics helping you to remain active for your lifetime.
Procedures using patented Regenexx SD injectate include a patented protocol that utilizes Bone Marrow Concentrate (BMC), which contains the patient’s own mesenchymal stem cells. The cell processing for a Regenexx SD injectate routinely achieves 20x concentration— far above what non-Regenexx cell processing can achieve.
Procedures using Regenexx SCP injectate represent a supercharged platelet-rich plasma (PRP) version. In this process, blood is drawn and then processed to isolate the platelets and growth factors. The growth factors are then purified, concentrated, and injected into the shoulder area using imaging guidance for precision. Regenexx-SCP injectate provides a higher concentration of growth factors than typical PRP procedures.